H. Lundbeck A/S

OTC
HLUBF
paper.types.company
Rentabilité sur six mois: -16.48%
Rendement en dividendes: 9.77%
Secteur: Healthcare

Calendrier des promotions H. Lundbeck A/S

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise H. Lundbeck A/S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.

plus de détails
It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with FeetMe focusing on the use of sensor shoe soles. H. Lundbeck A/S also has a collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
9.77
Дивиденд ао
0.2855
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 0.1996 10
P/BV 1.26 9
P/E 1.4 10
Efficacité
Nom Signification Grade
ROA 13.87 4
ROE 24.63 7
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 9.77 10
DSI 1 10
Croissance moyenne du dividende 17.15 10
Devoir
Nom Signification Grade
Debt/EBITDA 0.406 10
Debt/Ratio 0.293 10
Debt/Equity 1.28 8
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 41.6 6
Rentabilité Ebitda, % 35.58 5
Rentabilité EPS, % -54.71 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 3.7 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 3.7 $ 3.7 $ 3.7 $ 0 % 0 % 0 %
common.calendar.number_days.30d 3.7 $ 3.7 $ 3.7 $ 0 % 0 % 0 %
common.calendar.number_days.90d 3.67 $ 3.66 $ 4.35 $ 0.95 % 0 % 0 %
common.calendar.number_days.180d 4.43 $ 3.66 $ 4.63 $ -16.48 % 0 % 0 %
common.calendar.number_days.1y 6.1 $ 3.66 $ 6.65 $ -39.34 % 0 % 0 %
common.calendar.number_days.3y 3.8 $ 2.45 $ 6.65 $ -2.63 % 0 % 0 %
common.calendar.number_days.5y 0 $ 2.45 $ 6.65 $ 0 % 0 % 0 %
common.calendar.number_days.10y 0 $ 2.45 $ 6.65 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 4.43 $ 3.66 $ 4.43 $ -16.48 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Joerg Hornstein CFO & Executive VP of Corporate Functions 1.23M 1977 (48 années)
Mr. Lars Bang Executive Vice President of Product Development & Supply 1.14M 1962 (63 année)
Dr. Per Johan Luthman Executive Vice President of Research & Development 1.27M 1959 (66 années)
Mr. Charl van Zyl President & CEO 5.34M 1967 (58 années)
Dr. Tarek Samad Ph.D. Senior VP & Head of Research N/A
Mr. Palle Holm Olesen Chief Specialist & VP of Investor Relations N/A
Mr. Ole Chrintz Senior Vice President of International Markets N/A 1958 (67 années)
Dr. Rupert Sandbrink M.D., Ph.D. Senior VP & Head of Clinical Development N/A 1964 (61 année)
Ms. Tine Ostergaard Hansen Senior Vice President of Corporate Communications & Public Affairs N/A 1975 (50 années)
Ms. Dianne Holto Executive Vice President of People & Culture 1973 (52 année)

Informations sur l'entreprise

Adresse: Denmark, Valby, Ottiliavej 9 - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.lundbeck.com